NCT06811272
- Conditions
- Refractory Large B-cell Lymphoma, Relapsed Large B-cell Lymphoma
- Locations
-
- Massachusetts General Hospital Boston, Massachusetts, United States
- Newton-Wellesley Hospital Newton, Massachusetts, United States
Clinical trial condition
Refractory Large B-cell Lymphoma
Explore clinical trials studying Refractory Large B-cell Lymphoma. Study availability and eligibility vary by location and protocol.
4 public trials
3 recruiting studies
Refractory Large B-cell Lymphoma trial results
NCT04836507
- Conditions
- ALL (Acute B-Lymphoblastic Leukemia), Diffuse Large B-Cell Lymphoma (DLBCL), Hemic and Lymphatic Diseases, +15 more
- Locations
-
- Samsung Medical Center Seoul, South Korea
- The Catholic University of Korea Seoul St. Mary's Hospital Seoul, South Korea
NCT07473167
- Conditions
- Diffuse Large B-Cell Lymphoma (DLBCL), Hemic and Lymphatic Diseases, High-grade B-cell Lymphoma (HGBL), +14 more
- Locations
-
- Seoul National University Hospital Seoul, South Korea
NCT04002401
- Conditions
- Refractory Large B-cell Lymphoma
- Locations
-
- Banner MD Anderson Cancer Center Gilbert, Arizona, United States
- City of Hope National Medical Center Duarte, California, United States
- Stanford Cancer Institute Palo Alto, California, United States
- UCLA Hematology/Oncology Santa Monica, California, United States